| Followers | 139 |
| Posts | 6806 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2012 |
Saturday, April 17, 2021 8:56:35 PM
United States Patent Application Publication
Applicant: Regen Biopharma, Inc, La Mesa, CA
Wow! This is incredible medical science we are invested in here with Regen BioPharma!
https://patentimages.storage.googleapis.com/e2/04/ea/a176b1ba577f96/US20170246207A1.pdf
ABSTRACT
Disclosed are antigen specific cancer vaccines in which immunogenic epitopes are produced intracellularly by administration of modified mRNA encoding said immuno genic epitopes . In one embodiment of the invention , said modified mRNA encodes peptides derived from the protein survivin . By directly inducing gene expression of the anti gens to which an immune response is desired , immunogenic peptides are generated intracellularly , thus allowing for a wider repertoire of epitopes to be presented to the adaptive immune system , which augments likelihood of successful induction of immunity.
Blessings and best wishes,
LoveAndLight
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
